I'm not sure what some are expecting the company to do here. BOT have been very clear on where we are. 1503 follows Rosacea which goes until mid 22. AMR trial is being lined up. Dog itch is underway.
The catalysts for improving SP are productive results from these trials. Apart from some basic maintenance marketing they've done, it would appear they are happy to focus on getting the trials done and (fingers crossed) the market reacts to the de-risking of the company.
Don't get me wrong, 2.5 years in BOT has been a rollercoaster but I still believe in the science and their ability to convert. I check this board and the SP way less now as I don't expect much change until news is due.
Bot Chart, page-4981
-
- There are more pages in this discussion • 8,769 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |